Free Trial

AbbVie (ABBV) Short Interest Ratio & Short Volume

AbbVie logo
$171.49 -2.21 (-1.27%)
As of 01/17/2025 03:59 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

AbbVie Short Interest Data

AbbVie (ABBV) has a short interest of 17.00 million shares. This marks a -8.26% decrease in short interest from the previous month. The short interest ratio (days to cover) is 2.7, indicating that it would take 2.7 days of the average trading volume of 4.94 million shares to cover all short positions.

Current Short Interest
17,000,000 shares
Previous Short Interest
18,530,000 shares
Change Vs. Previous Month
-8.26%
Dollar Volume Sold Short
$3.02 billion
Short Interest Ratio
2.7 Days to Cover
Last Record Date
December 31, 2024
Outstanding Shares
1,767,140,000 shares
Percentage of Shares Shorted
0.96%
Today's Trading Volume
7,581,211 shares
Average Trading Volume
4,943,678 shares
Today's Volume Vs. Average
153%
Short Selling AbbVie?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for AbbVie and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

ABBV Short Interest Over Time

ABBV Days to Cover Over Time

ABBV Percentage of Float Shorted Over Time

AbbVie Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
12/31/202417,000,000 shares $3.02 billion -8.3%N/A2.7 $177.70
12/15/202418,530,000 shares $3.21 billion -4.1%N/A3 $173.37
11/30/202419,320,000 shares $3.53 billion -4.2%N/A3.3 $182.93
11/15/202420,170,000 shares $3.33 billion +11.3%N/A3.5 $164.91
10/31/202418,130,000 shares $3.70 billion +12.1%N/A3.7 $203.87
10/15/202416,180,000 shares $3.10 billion +8.9%0.9%3.4 $191.86
9/30/202414,860,000 shares $2.93 billion -16.5%0.8%3.2 $197.48
9/15/202417,790,000 shares $3.45 billion -8.7%1.0%3.5 $194.21
8/31/202419,490,000 shares $3.83 billion -3.5%1.1%3.7 $196.31
8/15/202420,190,000 shares $3.90 billion +15.2%1.2%3.7 $193.40
7/31/202417,530,000 shares $3.25 billion +7.0%1.0%3.2 $185.32
7/15/202416,380,000 shares $2.75 billion +1.0%0.9%3 $168.03
6/30/202416,220,000 shares $2.78 billion +6.4%0.9%3 $171.52
6/15/202415,250,000 shares $2.57 billion -7.5%0.9%2.9 $168.59
5/31/202416,490,000 shares $2.66 billion +3.5%0.9%2.9 $161.19
5/15/202415,930,000 shares $2.61 billion +10.0%0.9%2.9 $163.78
4/30/202414,480,000 shares $2.36 billion +6.9%0.8%2.6 $162.69
4/15/202413,540,000 shares $2.19 billion +3.2%N/A2.4 $161.67
3/31/202413,120,000 shares $2.39 billion -10.7%N/A2.3 $182.10
3/15/202414,690,000 shares $2.61 billion +2.9%0.8%2.7 $177.88
2/29/202414,270,000 shares $2.51 billion -3.3%0.8%2.6 $175.61
2/15/202414,750,000 shares $2.60 billion +7.5%0.8%2.8 $176.61
1/31/202413,720,000 shares $2.26 billion +1.2%0.8%2.5 $164.36
1/15/202413,560,000 shares $2.20 billion +12.3%0.8%2.4 $162.40
12/31/202312,080,000 shares $1.87 billion -11.8%0.7%2.2 $154.97
12/15/202313,690,000 shares $2.11 billion +23.0%0.8%2.6 $154.07
11/30/202311,130,000 shares $1.58 billion -0.2%0.6%2.2 $142.35
11/15/202311,150,000 shares $1.53 billion -15.7%0.6%2.4 $137.61
10/31/202313,230,000 shares $1.87 billion +15.3%0.8%3 $141.18
10/15/202311,470,000 shares $1.70 billion -6.8%0.7%2.6 $147.96
9/30/202312,310,000 shares $1.83 billion +3.2%0.7%2.7 $149.06
9/15/202311,930,000 shares $1.81 billion -4.2%0.7%2.4 $152.09
8/31/202312,450,000 shares $1.83 billion -6.1%0.7%2.4 $146.96
8/15/202313,260,000 shares $2.02 billion +15.9%0.8%2.3 $152.12
7/31/202311,440,000 shares $1.71 billion +20.3%0.7%2 $149.58
7/15/20239,510,000 shares $1.29 billion -8.2%0.5%1.6 $136.01
6/30/202310,360,000 shares $1.40 billion -8.4%0.6%1.8 $134.72
6/15/202311,310,000 shares $1.54 billion -0.6%0.6%2 $135.89
5/31/202311,380,000 shares $1.57 billion -4.9%0.7%1.9 $137.96
5/15/202311,970,000 shares $1.75 billion -23.5%0.7%2.1 $146.59
Grab This Altcoin Before Trump's Crypto Announcement (Ad)

The #1 Coin Poised to Soar Under Trump Pro-Crypto White House could make this the investment opportunity of a lifetime!

Click HERE to access this free report before it's too late
4/30/202315,650,000 shares $2.37 billion +3.4%0.9%2.6 $151.12
4/15/202315,140,000 shares $2.45 billion -7.0%N/A2.6 $161.59
3/31/202316,280,000 shares $2.59 billion +16.0%N/A2.6 $159.37
3/15/202314,040,000 shares $2.16 billion +10.6%N/A2.3 $154.06
2/28/202312,700,000 shares $1.95 billion +8.5%N/A2.3 $153.90
2/15/202311,710,000 shares $1.77 billion +13.7%N/A2.1 $151.06
1/31/202310,300,000 shares $1.52 billion -13.9%N/A1.8 $147.75
1/15/202311,960,000 shares $1.84 billion -7.5%N/A2.2 $153.60
12/30/202212,930,000 shares $2.09 billion -4.8%N/A2.5 $161.61
12/15/202213,580,000 shares $2.21 billion -0.6%N/A2.4 $163.10
11/30/202213,660,000 shares $2.20 billion +5.8%N/A2.4 $161.18
11/15/202212,910,000 shares $1.98 billion -6.5%N/A2.3 $153.04
10/31/202213,800,000 shares $2.02 billion -1.4%N/A2.6 $146.40
10/15/202214,000,000 shares $2.00 billion +5.3%N/A2.6 $142.94
9/30/202213,290,000 shares $1.78 billion +2.6%N/A2.4 $134.21
9/15/202212,950,000 shares $1.85 billion +13.8%N/A2.4 $142.51
8/31/202211,380,000 shares $1.53 billion -12.5%N/A2.1 $134.46
8/15/202213,010,000 shares $1.85 billion -6.1%N/A2.2 $142.29
7/31/202213,850,000 shares $1.99 billion -1.3%0.8%2.2 $143.51
7/15/202214,030,000 shares $2.16 billion -2.7%0.8%2.1 $153.62
6/30/202214,420,000 shares $2.21 billion +6.7%1.0%2 $153.16
6/15/202213,520,000 shares $1.87 billion +6.0%0.9%1.9 $138.09
5/31/202212,750,000 shares $1.88 billion -10.4%0.7%1.8 $147.37
5/15/202214,230,000 shares $2.18 billion +8.2%0.8%1.9 $153.50
4/30/202213,150,000 shares $1.93 billion +9.0%0.8%1.7 $146.88
4/15/202212,070,000 shares $1.96 billion -10.2%0.7%1.5 $162.31
3/31/202213,440,000 shares $2.18 billion -9.7%0.8%1.7 $162.11
3/15/202214,890,000 shares $2.32 billion -6.9%N/A1.9 $155.88
2/28/202215,990,000 shares $2.36 billion +3.9%N/A2 $147.77
2/15/202215,390,000 shares $2.23 billion -4.7%N/A2 $144.76
1/31/202216,150,000 shares $2.21 billion +12.7%0.9%2.3 $136.89
1/15/202214,330,000 shares $1.95 billion -13.7%0.8%2.2 $135.87
12/31/202116,610,000 shares $2.25 billion +7.6%0.9%2.7 $135.40
12/15/202115,440,000 shares $2.01 billion +9.4%0.9%2.5 $130.23
11/30/202114,120,000 shares $1.63 billion +0.2%N/A2.3 $115.28
11/15/202114,090,000 shares $1.65 billion +3.5%0.8%2 $116.84
10/29/202113,620,000 shares $1.56 billion +18.5%0.8%1.9 $114.67
10/15/202111,490,000 shares $1.26 billion -16.0%0.7%1.6 $109.33
9/30/202113,670,000 shares $1.47 billion +5.2%0.8%1.9 $107.87
9/15/202112,990,000 shares $1.40 billion -4.1%0.7%1.9 $107.77
8/31/202113,550,000 shares $1.64 billion +3.5%0.8%2 $120.78
8/13/202113,090,000 shares $1.52 billion -9.4%0.7%2.2 $116.48
7/30/202114,450,000 shares $1.68 billion -1.4%0.8%2.3 $116.30
7/15/202114,660,000 shares $1.72 billion +6.5%0.8%2.3 $117.18
6/30/202113,770,000 shares $1.55 billion +3.2%0.8%2.2 $112.64
6/15/202113,340,000 shares $1.55 billion -9.6%0.8%2 $115.83
5/28/202114,760,000 shares $1.67 billion -3.4%0.8%2.1 $113.20
5/14/202115,280,000 shares $1.78 billion +2.6%N/A2.2 $116.60
4/30/202114,890,000 shares $1.65 billion -20.4%N/A2.2 $110.89
4/15/202118,710,000 shares $1.98 billion +11.4%N/A2.6 $105.90
Grab This Altcoin Before Trump's Crypto Announcement (Ad)

The #1 Coin Poised to Soar Under Trump Pro-Crypto White House could make this the investment opportunity of a lifetime!

Click HERE to access this free report before it's too late
3/31/202116,800,000 shares $1.79 billion +3.7%N/A2.3 $106.79
3/15/202116,200,000 shares $1.75 billion +5.0%N/A2.2 $108.22
2/26/202115,430,000 shares $1.66 billion +8.1%N/A2.2 $107.33
2/12/202114,280,000 shares $1.48 billion -4.0%N/A1.9 $103.75
1/29/202114,870,000 shares $1.55 billion +18.1%N/A1.9 $104.21
1/15/202112,590,000 shares $1.41 billion -5.6%N/A1.5 $111.63
12/31/202013,330,000 shares $1.40 billion -3.8%N/A1.6 $105.27
12/15/202013,850,000 shares $1.44 billion +4.4%N/A1.7 $104.20
11/30/202013,270,000 shares $1.39 billion -5.2%N/A1.6 $104.89
11/15/202014,000,000 shares $1.39 billion +9.0%N/A1.7 $99.04
10/30/202012,840,000 shares $1.04 billion +20.7%N/A1.6 $80.67
10/15/202010,640,000 shares $915.78 million -17.8%N/A1.5 $86.07
9/30/202012,940,000 shares $1.13 billion -2.6%N/A1.9 $87.59
9/15/202013,280,000 shares $1.21 billion +9.2%N/A1.9 $90.91
8/31/202012,160,000 shares $1.16 billion -2.0%N/A1.7 $95.77
8/14/202012,410,000 shares $1.18 billion -6.3%N/A1.7 $95.07
7/31/202013,240,000 shares $1.26 billion -3.2%N/A1.5 $94.91
7/15/202013,680,000 shares $1.37 billion -15.6%N/A1.4 $100.48
6/30/202016,210,000 shares $1.59 billion -18.0%N/A1.6 $98.18
6/15/202019,760,000 shares $1.84 billion +2.9%N/A1.8 $93.08
5/29/202019,200,000 shares $1.78 billion -22.6%N/A1.5 $92.67
5/15/202024,800,000 shares $2.25 billion -70.9%N/A1.8 $90.71
4/30/202085,240,000 shares $7.01 billion +0.6%5.8%6.6 $82.20
4/15/202084,730,000 shares $6.93 billion +0.1%5.8%6.8 $81.82
3/31/202084,640,000 shares $7.08 billion +3.7%5.8%6.8 $83.59
3/13/202081,623,800 shares $6.51 billion +5.0%5.5%8.8 $79.75
2/28/202077,760,000 shares $5.02 billion -1.6%N/A8.4 $64.50
2/14/202079,020,000 shares $6.92 billion +5.7%N/A9.4 $87.53
1/31/202074,740,000 shares $6.61 billion -2.5%N/A9 $88.41

ABBV Short Interest - Frequently Asked Questions

What is AbbVie's current short interest?

Short interest is the volume of AbbVie shares that have been sold short but have not yet been covered or closed out. As of December 31st, traders have sold 17,000,000 shares of ABBV short. Learn More on AbbVie's current short interest.

What is a good short interest ratio for AbbVie?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ABBV shares currently have a short interest ratio of 3.0. Learn More on AbbVie's short interest ratio.

Which institutional investors are shorting AbbVie?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of AbbVie: Portman Square Capital LLP, NorthCrest Asset Manangement LLC, Wealth Enhancement Advisory Services LLC, JPMorgan Chase & Co., Barclays PLC, Jane Street Group LLC, Wolverine Trading LLC, Readystate Asset Management LP, Point72 DIFC Ltd, Parallax Volatility Advisers L.P., Maven Securities LTD, HighTower Advisors LLC, Centiva Capital LP, Verition Fund Management LLC, Capstone Investment Advisors LLC, Walleye Trading LLC, Walleye Capital LLC, PEAK6 Investments LLC, BNP Paribas Financial Markets, DRW Securities LLC, Citigroup Inc., Marathon Trading Investment Management LLC, Gladius Capital Management LP, Wolverine Asset Management LLC, SpiderRock Advisors LLC, Genus Capital Management Inc., Wealth Enhancement Advisory Services LLC, and NorthCrest Asset Manangement LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Is AbbVie's short interest increasing or decreasing?

AbbVie saw a drop in short interest during the month of December. As of December 31st, there was short interest totaling 17,000,000 shares, a drop of 8.3% from the previous total of 18,530,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does AbbVie's short interest compare to its competitors?

Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to AbbVie: Eli Lilly and Company (0.72%), Johnson & Johnson (0.69%), Merck & Co., Inc. (1.22%), Pfizer Inc. (1.34%), Bristol-Myers Squibb (1.23%), Zoetis Inc. (1.55%), Royalty Pharma plc (4.35%), Jazz Pharmaceuticals plc (6.65%), Corcept Therapeutics Incorporated (17.68%), Perrigo Company plc (3.30%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.83 billion), Charter Communications, Inc. ($3.77 billion), Reddit, Inc. ($2.98 billion), The Kroger Co. ($2.97 billion), International Paper ($2.64 billion), SoFi Technologies, Inc. ($1.99 billion), Rivian Automotive, Inc. ($1.93 billion), Onsemi ($1.81 billion), SoundHound AI, Inc. ($1.59 billion), and Moderna, Inc. ($1.57 billion). View all of the most shorted stocks.

What does it mean to sell short AbbVie stock?

Short selling ABBV is an investing strategy that aims to generate trading profit from AbbVie as its price is falling. ABBV shares are trading down $2.21 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against AbbVie?

A short squeeze for AbbVie occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ABBV, which in turn drives the price of the stock up even further.

How often is AbbVie's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ABBV, twice per month. The most recent reporting period available is December, 31 2024.




This page (NYSE:ABBV) was last updated on 1/20/2025 by MarketBeat.com Staff
From Our Partners